...
首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Alteration in plasma levels of nonprotein sulfhydryl compounds and S-nitrosothiols in chronic renal failure patients.
【24h】

Alteration in plasma levels of nonprotein sulfhydryl compounds and S-nitrosothiols in chronic renal failure patients.

机译:慢性肾衰竭患者血浆中非蛋白质巯基化合物和S-亚硝基硫醇的血浆水平变化。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Uremia is accompanied by the elevated nitric oxide (NO) synthesis, and it has not yet been established how this influences the levels of nonprotein sulfhydryl compounds (NPSH) and formation of S-nitrosothiols (SNT). METHODS: Our study was designed to determine plasma levels of SNT and NPSH in chronic renal failure (CRF) patients, who were hemodialysed (HD) or were not on hemodialysis treatment (ND), and in the control group. RESULTS: In ND patients, the plasma levels of SNT were significantly increased (11.25+/-2.08 nmol/ml, p<0.01), while NPSH levels were simultaneously decreased (66.67+/-15.0 nmol/ml, p<0.05) in comparison with the control subjects (SNT: 8.75+/-2.08 nmol/ml, NPSH: 86.66 nmol/ml). In HD patients, plasma concentration of SNT before hemodialysis was significantly lower than in the control group (0.150+/-0.042 nmol/mg protein vs. control: 0.175+/-0.075 nmol/mg protein), and no significant change was observed after dialysis (0.142+/-0.058 nmol/mg protein, p<0.05). The level ofNPSH in HD patients before dialysis was significantly decreased in comparison with the control subjects, both, when the results were calculated per 1 ml of plasma (45.96+/-17.87 nmol/ml) and per 1 mg of protein (0.70+/-0.25 nmol/mg protein). In the postdialysis samples, NPSH rose (79.15+/-22.9 nmol/ml, p<0.001 which corresponds to 1.30+/-0.55 nmol/mg protein, p<0.001) as compared to the level before dialysis. CONCLUSIONS: Firstly, plasma SNT level was found to be increased in CRF patients who were not treated with hemodialysis, while in HD patients, it dropped below the control values. It indicates that hemodialysis disturbs an equilibrium of reactions involved in S-nitrosothiols formation most probably by removing low molecular weight S-nitrosylating compounds. Secondly, the increased level of NPSH after each hemodialysis session indicates reestablished antioxidant capacity of plasma and suggests the existence of dialysable compounds, which via unknown mechanism become responsible for the decreased level of thiols.
机译:背景:尿毒症伴随着一氧化氮(NO)合成的增加,并且尚未确定这如何影响非蛋白质巯基化合物(NPSH)的水平和S-亚硝基硫醇(SNT)的形成。方法:本研究旨在确定接受血液透析(HD)或未接受血液透析治疗(ND)的慢性肾衰竭(CRF)患者的血浆SNT和NPSH水平。结果:在ND患者中,SNT的血浆水平显着升高(11.25 +/- 2.08 nmol / ml,p <0.01),而NPSH水平同时降低(66.67 +/- 15.0 nmol / ml,p <0.05)。与对照受试者比较(SNT:8.75 +/- 2.08nmol / ml,NPSH:86.66nmol / ml)。在HD患者中,血液透析前的SNT血浆浓度显着低于对照组(0.150 +/- 0.042 nmol / mg蛋白质相对于对照组:0.175 +/- 0.075 nmol / mg蛋白质),并且在透析后未观察到明显变化透析(0.142 +/- 0.058nmol / mg蛋白质,p <0.05)。当计算每1 ml血浆(45.96 +/- 17.87 nmol / ml)和每1 mg蛋白质(0.70 + //)时,透析前HD患者的NPSH水平与对照组相比均显着降低。 -0.25 nmol / mg蛋白)。在透析后样品中,与透析前的水平相比,NPSH升高(79.15 +/- 22.9 nmol / ml,p <0.001,对应于1.30 +/- 0.55 nmol / mg蛋白,p <0.001)。结论:首先,未进行血液透析治疗的CRF患者血浆SNT水平升高,而在HD患者中血浆SNT水平降至控制值以下。这表明血液透析最有可能通过去除低分子量的S-亚硝基化化合物而扰乱了S-亚硝基硫醇形成过程中涉及的反应平衡。其次,每次血液透析后NPSH水平的升高表明血浆抗氧化能力已恢复,并暗示存在可透析的化合物,这通过未知机理导致了硫醇水平的降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号